Carregant...
ASXL1 as a critical regulator of epigenetic marks and therapeutic potential of mutated cells
Guardat en:
| Publicat a: | Oncotarget |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Impact Journals LLC
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6219660/ https://ncbi.nlm.nih.gov/pubmed/30443287 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.26230 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|